Search

everythinglearnresearchcommunity

for

Search:↓

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Your genes, especially IL-1a, can predict how well a hair growth treatment with platelet rich plasma will work for you.

DDR-II hair follicle cells don't respond to 1, 25-dihydroxyvitamin D3, aiding diagnosis.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

Certain genes may be linked to autoimmune conditions in people with alopecia areata.

Lgr5+ stem cells do not cause skin tumors.

A new mutation, Glu402Lys, in hair keratin is linked to variable symptoms of monilethrix.

The gene for Marie Unna hereditary hypotrichosis is located on chromosome 8p21.

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Changing how mesenchymal stromal cells are grown can improve their healing abilities.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Hidradenitis suppurativa, a chronic skin disease, can be managed with antibiotics, lifestyle changes, and in severe cases, surgery. Early diagnosis and careful planning are key, and laser treatment can be an efficient solution for mild to severe cases.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.